Abstract
Re: Jaffe et al.: C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2/3 trial (Ophthalmology. 2021;128:576–586)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have